Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chi

Showing results (821-830 of 903) with videos related to

Pageof 91
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013A Oseledchyk, M M Leitao, J Konner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Scientific Reports|November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports|June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2022
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservationBeryl Manning-Geist, Sushmita Gordhandas, Anjelica Hodgson, et al.
Plos Genetics|November 1, 2008
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domainsManching Ku, Richard P Koche, Esther Rheinbay, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2020
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patientsAnton Oseledchyk, Mary L Gemignani, Qin C Zhou, et al.
Pageof 91

Showing results (821-830 of 903) with videos related to

Sort By:
Pageof 91
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013A Oseledchyk, M M Leitao, J Konner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 29, 2025
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Scientific Reports|November 22, 2018
Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Scientific Reports|June 15, 2019
Publisher Correction: Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRIK Ina Ly, Bella Vakulenko-Lagun, Kyrre E Emblem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 11, 2022
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservationBeryl Manning-Geist, Sushmita Gordhandas, Anjelica Hodgson, et al.
Plos Genetics|November 1, 2008
Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domainsManching Ku, Richard P Koche, Esther Rheinbay, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2020
Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patientsAnton Oseledchyk, Mary L Gemignani, Qin C Zhou, et al.
Pageof 91